Asusi, Gwendoline .
HRN: 26-26-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
11/29/2024
12/06/2024
IV
300mg
OD
Endomet
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes